Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 489.23 | (78.83) | (71.46)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 558.02 | (38.32) | (39.08)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| Abbott in $6.6 Billion Deal for Drug Unit | 29-Sep-2009 | New York Times |
| BioMarin Halts Trials of Neutralase Heart Drug | 23-Sep-2003 | LA Times |
| Genzyme, BioMarin Drug OKd in Europe | 12-Jun-2003 | LA Times |
| Currency | US Dollars |
| Share Price | $ 38.64 |
| Change Today | $ 0.13 |
| % Change | 0.34 % |
| 52 Week High | $38.80 |
| 52 Week Low | $24.02 |
| Volume | 792,216 |
| Shares Issued | 115.70m |
| Market Cap | $4,470.69m |
| Beta | 0.79 |
| RiskGrade | 142 |
| Strong Buy | 13 |
| Buy | 2 |
| Neutral | 4 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 19 |

| Time | Volume / Share Price |
| 16:00 | 4,100 @ $38.64 |
| 16:00 | 7,549 @ $38.64 |
| 15:59 | 300 @ $38.65 |
| 15:59 | 300 @ $38.65 |
| 15:59 | 200 @ $38.65 |
You are here: research